MutationForecaster® (mutationforecaster.com) is Cytognomix’s patented web-portal for analysis of all types of mutations – coding and non-coding- including interpretation, comparison and management of genetic variant data. It’s a fully automated genome interpretation solution for research, translational and clinical labs.
Run our world-leading genome interpretation software on your exome, gene panel, or complete genome (Shannon transcription factor and splicing pipelines, ASSEDA, Veridical) with the Cytognomix User Variation Database and Variant Effect Predictor. With our integrated suite of software products, analyze coding, non-coding, and copy number variants, and compare new results with existing or your own database. Select predicted mutations by phenotype using articles with CytoVisualization Analytics. With Workflows, automatically perform end-to-end analysis with all of our software products. Download an 1 page overview of MutationForecaster® (link)
Subscribe and analyze your own data via the cloud or… Don’t want to run your own analyses on MutationForecaster®? Let us do it for you with our Bespoke Analysis Service.
Experience our suite of genome interpretation products through a free trial of MutationForecaster®. Once you register, we provide datasets from our peer-reviewed publications to evaluate these software tools.
Automated radiation biodosimetry
Ionizing radiation produces characteristic chromosome changes. The altered chromosomes are known as dicentric chromosomes [DCs]). DC biodosimetry is approved by the IAEA for occupational radiation exposure, radiation emergencies, or monitoring long term exposures. The DC assay can also monitor effects of interventional radiation therapies.
Cytognomix has developed a novel approach to find DCs (TBME). The Automated Dicentric Chromosome Identifier and Dose Estimator (ADCI) software works on multiple platforms and uses images produced by any of the existing automated metaphase capture systems found in most cytogenetic laboratories. ADCI is now available for for trial or purchase (link). Or contact us for details (pricing).
ADCI* uses machine learning to distinguish monocentric and dicentric chromosomes (Try the Dicentric Chromosome Identifier web app). With novel image segmentation, ADCI has become a fully functional cytogenetic biodosimetry system. ADCI takes images from metaphase scanning systems, selects high quality cells, identifies dicentric chromosomes, builds biodosimetry calibration curves, and estimates exposures. ADCI fulfills the criteria established by the IAEA for accurate triage biodosimetry of a sample in less than an hour. The accuracy is comparable to an experienced cytogeneticist. Check out our online user manual: wiki.
We find and validate mutations and gene signatures that others cannot with advanced, patented genomic bioinformatic technologies. Cytognomix continues our long track record of creating technologies for genomic medicine. We anticipate and implement the needs of the molecular medicine and genomics communities.
Predict chemotherapy outcomes
Pharmacogenomic responses to chemotherapy drugs can be predicted by supervised machine learning of expression and copy number of relevant gene combinations. Since 2015, CytoGnomix has used biochemical evidence to derive gene signatures from changes in gene expression in cell lines, which can subsequently be examined in patients that have been treated with the same drugs. We have derived signatures for 30 different commonly used drugs. Try out out our online predictor: https://chemotherapy.cytognomix.com.
Quantifying responses to ionizing radiation with gene expression signatures.
Gene signatures derived by machine learning have low error rates in externally validated, independent radiation exposed data. They exhibit high specificity and granularity for dose estimation in humans and mice. These signatures can be designed to avoid the effects of confounding, comorbidities which can reduce specificity for detecting radiation exposures. See: https://f1000research.com/articles/7-233/v2
Single copy genomic technologies
- Customized genomic microarrays
- Ultrahigh resolution FISH probes (article):
- Microarray-based comparative genomic hybridization (aCGH) can use SC technology to increase reproducibility and reduce cost per sample.
May 25, 2023. CytoGnomix to present at final RCP meeting of IAEA CRP E35010 (MEDBIODOSE)
Nov. 23, 2022. Our new handle to contact Peter Rogan and CytoGnomix
We have set up a new address on Mastodon (to replace our Twitter handle): PeterKRogan@mstdn.ca (https://mstdn.ca/@PeterKRogan)
Nov. 16, 2022. Article accepted about determination of radiation exposures using a worldwide cloud computing platform
“The Automated Dicentric Chromosome (DC) Identifier and Dose Estimator System (ADCI) selects and processes images to identify DCs and determines radiation dose without manual review. The goal of this study was to broaden accessibility and speed of this system with data parallelization while protecting data and software integrity.”
Nov. 15, 2022. New US Patent on radiation biodosimetry
The US Patent and Trademark office as issued our patent number 11,501,545 titled “Smart Microscope System for Radiation Biodosimetry.” It has the same title as our previous patent no. 10,929,641, but there are some important differences. This one claims a broader spectrum of applications for estimation of absorbed radiation dose because it doesn’t require the […]
Nov. 7-10, 2022. Presentation on population scale biodosimetry at International Symposium on the System of Radiological Protection
Presenting “Population-scale biodosimetry for management of ionizing radiation incidents” at the International Symposium on the System of Radiological Protection in Vancouver, 7-10 Nov 2022. The presentation is publicly available at the Learning Toolbox at: https://api.ltb.io/show/ABQBH
Nov. 1-3, 2022. Presentation at the International Atomic Energy Agency
October 17, 2022. Presentation at the International Symposium on the System of Radiological Protection (ICRP)
We are presenting: “Population-scale biodosimetry for management of ionizing radiation incidents” 2021+1 International Congress of Radiation Protection (ICRP) Vancouver BC, 7-10 November 2022, with Ruth Wilkins, Ed Waller and Joan Knoll. (https://icrp2021.com/)
October 14, 2022. Interview with editors of F1000 Research about geospatial data analysis of COVID-19 study
Blog about our publication on community level tracking of COVID-19 in Ontario, Canada: The power of data: using geospatial analysis to support COVID-19 decision-making